Guidance for Savient Pharmaceuticals, Inc. (VNT)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2026 $3.35 – $3.50 $3.44 N/A N/A = Maintained Details
2026 $3.35 – $3.50 $3.41 N/A N/A = Maintained Details
Q2 2026 $0.78 – $0.81 $0.82 N/A N/A = Maintained Details
Q1 2026 $0.78 – $0.81 $0.81 N/A N/A = Maintained Details
2025 $3.15 – $3.20 $3.18 N/A N/A = Maintained Details
2025 $3.10 – $3.20 $3.12 $3.02B – 3.07B $3.02B = Maintained Details
2025 $3.00 – $3.15 $3.09 N/A N/A = Maintained Details
2025 $3.00 – $3.15 $3.13 $2.97B – 3.05B $3.07B = Maintained Details
Q4 2025 $0.82 – $0.86 $0.86 N/A N/A = Maintained Details
Q3 2025 $0.74 – $0.78 $0.78 $745.00M – 755.00M $755.40M = Maintained Details
Q2 2025 $0.70 – $0.75 $0.72 N/A N/A = Maintained Details
Q1 2025 $0.71 – $0.74 $0.74 $715.00M – 730.00M $737.60M = Maintained Details
2024 $2.86 – $2.92 $2.85 $2.96B – 2.99B $2.95B = Maintained Details
2024 $2.80 – $3.00 $3.09 $2.90B – 3.00B $3.08B = Maintained Details
2024 $3.00 – $3.15 $3.12 $3.04M – 3.10M $3.12M = Maintained Details
Q3 2024 $0.67 – $0.71 $0.78 $715.00M – 740.00M $768.70M = Maintained Details
Q2 2024 $0.67 – $0.71 $0.73 $735.00M – 750.00M $762.20M = Maintained Details
Q1 2024 $3.00 – $3.15 N/A N/A N/A = Maintained Details
2023 $2.79 – $2.87 $2.86 N/A N/A = Maintained Details
2023 $2.77 – $2.87 $2.80 N/A N/A = Maintained Details
2023 $2.73 – $2.83 $2.75 N/A N/A = Maintained Details
Q3 2023 $0.65 – $0.69 $0.65 N/A N/A = Maintained Details
Q2 2023 $0.61 – $0.66 $0.64 N/A N/A = Maintained Details
2022 $3.00 – $3.05 $3.22 N/A N/A = Maintained Details
2022 $3.20 – $3.30 N/A N/A N/A = Maintained Details
2021 $2.82 – $2.86 $2.79 N/A N/A = Maintained Details
2021 $2.55 – $2.65 $2.45 N/A N/A = Maintained Details
2021 $2.35 – $2.45 N/A N/A N/A = Maintained Details
Q2 2021 $0.50 – $0.54 $0.53 N/A N/A = Maintained Details
Q1 2021 $0.52 – $0.55 N/A N/A N/A = Maintained Details